// App-Quantinova.ai

: Adapting asthma clinical trials in response to the COVID-19 pandemic - the BenRex study design

Researchers

Presenter

  • Steven Smith

Principal Investigators

  • Liam Heaney

  • Christopher Brightling

  • Alex Mcconnachie

  • Salman Siddiqui

  • Vijay Mistry

  • Vanessa Brown

  • David Jackson

  • Nicola Lee

  • Stephen Fowler

  • Adel Mansur

  • Hassan Burhan

  • Dinesh Saralaya

  • Ramesh Kurukulaaratchy

  • Shuaib Nasser

  • Paul Pfeffer

  • Thomas Brown

  • James Lordan

  • Ian Pavord

  • Rekha Chaudhuri

Medical Centers

  • Research and Innovation, Glasgow, United Kingdom

  • Guy’s Severe Asthma Centre, Guy’s & St Thomas’ Hospitals; King’s College London, London, United Kingdom

  • University of Oxford, Oxford, United Kingdom

  • Gartnavel General Hospital and University of Glasgow, Glasgow, United Kingdom

  • Gartnavel General Hospital, Glasgow, United Kingdom

  • School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre and NIHR Manchester, Manchester, United Kingdom

  • Queen's University Belfast, Belfast, United Kingdom

  • Birmingham Children's Hospital, Birmingham, United Kingdom

  • Addenbrookes Hospital, Cambridge, United Kingdom

  • Freeman Hospital, Newcastle upon Tyne, United Kingdom

  • Guy's Hospital, London, United Kingdom

  • NIHR National Patient Recruitment Centre, Bradford, United Kingdom

  • University of Southampton, Southampten, United Kingdom

  • Royal Liverpool University Hospital, Liverpool, United Kingdom

  • Queen Alexandra Hospital, Portsmouth, United Kingdom

  • Robertson Centre for Biostatistics, Glasgow, United Kingdom

  • University of Manchester, Manchester, United Kingdom

  • University of Leeds, Leeds, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Autoimmune (AI)

Disease

  • Coronavirus disease

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • Benralizumab

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • NCT04102800

Sponsors

  • N/A

Result

  • N/A